Search

Rapid ECDC advice on infection prevention and control measures for Ebola disease in EU/EEA healthcare settings

• 2 June 2026

This document aims to provide guidance for public health, healthcare providers and infection prevention and control (IPC) professionals in the EU/EEA regarding IPC measures should there be individuals meeting the criteria for ‘person under investigation’ (PUI).

Risk assessment guidelines for infectious diseases transmitted on aircraft (RAGIDA) – Ebola disease update

• 30 May 2026

The ongoing outbreak of Ebola disease caused by Bundibugyo virus in the Democratic Republic of the Congo (DRC) and Uganda reported in May 2026 has prompted ECDC to review its operational guidance relevant to air travel. In this context, updated guidance is needed to support preparedness and public health action if a case is identified during or after a flight.

ECDC/EC/EFSA country visit to Serbia to advance One Health responses against antimicrobial resistance

• 26 May 2026

The European Centre for Disease Prevention and Control (ECDC), the European Commission’s Directorate-General for Health and Food Safety (DG SANTE) and the European Food Safety Authority (EFSA) conducted a country visit to Serbia from 24 to 28 February 2025.

Threat assessment brief: Ebola disease outbreak caused by Bundibugyo virus – Democratic Republic of the Congo and Uganda – 2026

• 21 May 2026

On 15 May 2026, Africa CDC reported an outbreak of Ebola disease in Ituri Province, DRC. Laboratory analysis at Institut National de Recherche Biomedicale of DRC identified Bundibugyo virus (BDBV). BDBV disease is a rare disease but can cause outbreaks with high case fatality rates. Considering the available information, complicated context and the uncertainties on the epidemiological information WHO declared a Public Health Emergency of International Concern on 17 May 2026. Africa CDC declared a Public Health Emergency of Continental Security on 18 May 2026.

Rapid scientific advice on infection, prevention and control measures for patients in healthcare settings with Andes virus (ANDV) disease

• 15 May 2026

This document aims to provide advice on infection prevention and control (IPC) measures for healthcare facilities providing care to patients with suspected or confirmed ANDV disease.

Eleventh external quality assessment scheme for Listeria monocytogenes typing in EU/EEA and EU enlargement countries, 2024

• 11 May 2026

This report presents the results of the eleventh round of the external quality assessment (EQA-11) scheme for Listeria monocytogenes (L. monocytogenes) typing in the EU/EEA, organised for national public health reference laboratories
(NPHRLs) providing data to the Food- and Waterborne Diseases and Zoonoses Network (FWD-Net), managed by ECDC.

Rapid scientific advice on the management of passengers - In the context of the Andes virus outbreak on the cruise ship MV Hondius

• 9 May 2026

This document provides advice for public health professionals in the EU/EEA managing individuals potentially exposed to Andes virus infection.

Threat assessment brief: Hantavirus-associated cluster of illness on a cruise ship: ECDC assessment and recommendations

• 6 May 2026

As of 6 May 2026, seven cases have been reported in a hantavirus-associated cluster of illness on a cruise ship, including three deaths, one critically ill, two symptomatic and one with unknown status.

ECDC review of communicable disease surveillance in Ukraine

• 13 April 2026

ECDC cooperates with countries under the EU enlargement policy to improve their infectious disease prevention and control systems and public health workforce and prepare them for their future participation in ECDC’s work.

Rapid ECDC advice on the designation of future European Reference Laboratories for public health

• 23 February 2026

This document is an update of the rapid scientific advice published in June 2025. It contains recommendations on the EURL(s) for public health to be implemented under the 2026 EU4Health Work Programme.

Multi-country foodborne event caused by cereulide in infant formula products

• 19 February 2026

From 19 December 2025 to 13 February 2026, six EU countries and the United Kingdom reported infants with gastrointestinal symptoms following the consumption of contaminated infant formula.

ECDC country visit to Kosovo to discuss surveillance of communicable diseases

• 28 January 2026

ECDC conducted a technical visit to Kosovo in March 2025 to obtain additional information on the country’s national surveillance system.

Country report: ECDC Public Health Emergency Preparedness Assessment for France, 2025

• 27 January 2026

This report presents the findings and recommendations of the first assessment conducted in France.

ECDC country visit to Türkiye to discuss surveillance of communicable diseases

• 20 January 2026

ECDC conducted a technical visit to Türkiye in April 2025 to obtain a comprehensive overview of the country’s national surveillance system, including its operation and governance, its needs, vulnerabilities and strengths.

Multi-model analysis to quantify the impact of vaccination on COVID-19 and influenza hospitalisation burden among older adults in the EU/EEA, 2024/25

• 16 December 2025

Influenza vaccine coverage remains below the WHO-recommended threshold for risk groups in most EU/EEA countries, while COVID-19 vaccine coverage is declining across most countries.

Country report: ECDC Public Health Emergency Preparedness Assessment for Finland, 2024 - Under Article 8 of the Regulation (EU) 2022/2371

• 8 December 2025

This report presents the findings and recommendations of the second assessment in the three-year programme, conducted in Finland.

Threat Assessment Brief: Assessing the risk of influenza for the EU/EEA in the context of increasing circulation of A(H3N2) subclade K

• 20 November 2025

Circulating respiratory viruses, including influenza viruses, SARS-CoV-2 and RSV, all contribute to pressure on healthcare systems during winter in the EU/EEA.

Rapid scientific advice on protecting infants against respiratory syncytial virus disease for the European 2025/26 winter season

• 13 November 2025

The 2025/26 season for respiratory diseases is starting in Europe, marked by increased detections of respiratory syncytial virus (RSV) in several countries and rising rates of influenza-like illness infections in primary care settings.

A living systematic review and meta analysis on the efficacy and safety of respiratory syncytial virus vaccines

• 13 November 2025

Respiratory syncytial virus (RSV) is a prevalent and pervasive highly transmissible virus within the family Pneumoviridae, leading to respiratory illness of varying severity in humans. Most individuals experience their initial infection during early childhood, with near universal exposure by age two.

Threat Assessment Brief: Detection of autochthonous transmission of monkeypox virus clade Ib in the EU/EEA

• 24 October 2025

This Threat Assessment Brief aims to assess the risk of autochthonous transmission of monkeypox virus (MPXV) clade Ib in EU/EEA countries in the context of male-to-male sexual transmission. It is intended for public health authorities in EU/EEA countries and is based on currently available evidence.

Prolonged multi-country outbreak of Salmonella Strathcona ST2559 linked to consumption of tomatoes in the European Union/European Economic Area – first update

• 23 October 2025

A prolonged cross-border outbreak of Salmonella Strathcona ST2559 is ongoing in the European Union/European Economic Area (EU/EEA). From 2023 to 30 September 2025, 437 confirmed cases of S. Strathcona ST2559 were identified in 17 EU/EEA countries (205 additional cases since the first rapid outbreak assessment published on 12 November 2024).

ECDC country visit to Moldova to discuss surveillance of communicable diseases

• 22 October 2025

ECDC cooperates with countries under the EU enlargement policy to improve their infectious disease prevention and control systems and public health workforce to prepare them for their future participation in ECDC’s work.

Final report from the audit of the HIV pre-exposure prophylaxis standards of care

• 17 October 2025

The current report presents findings from a clinical audit conducted on the PrEP Standards of Care module developed by ECDC in collaboration with EACS, which also serves as a model for future audits on other care standards.

Country report: ECDC Public Health Emergency Preparedness Assessment for Iceland, 2025

• 13 October 2025

This report presents the findings and recommendations of an assessment conducted in Iceland. This involved a desk review of relevant documents, followed by a five-day country visit that took place between 2 June and 6 June 2025.

Country report: ECDC Public Health Emergency Preparedness Assessment for Latvia, 2025

• 10 October 2025

ECDC has the responsibility, in coordination with relevant Union agencies and bodies, to conduct Public Health Emergency Preparedness Assessments of all EU/EEA countries every three years regarding the state of implementation of their national prevention, preparedness and response planning.